Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation

NCT01593124 is registered in ClinicalTrials.gov with CONRAD as lead sponsor.

NCT NCT01593124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01593124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation
Lead sponsor
CONRAD
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
April 30, 2013
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vaginal infections, vaginal inflammation